Clinical Efficacy of Vector Paro With Hydroxyapatite in the Supportive Therapy of Periodontitis

Inclusion Criteria

• •Signed Informed Consent Form.
• •Male and female subjects, aged 18-75 years, inclusive.
• •Good general health (free of systemic diseases such as diabetes, HIV infection or genetic disorder, ongoing malignant disease of any type that could influence the outcome of the treatment and might interfere with the evaluation of the study objectives).
• •History of periodontitis staging III or IV grading B or C
• •At least 4 sites (split mouth 2 - 2) with probing depth ≥6 mm or pockets of 5 mm with bleeding on probing.
• •Previous periodontal non-surgical treatment at least 3 months maximum 6 months.
• •Availability for the 6-month duration of the study for an assigned subject.